Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Genesis AI Corp C.AIG

Alternate Symbol(s):  AIGFF

Genesis AI Corp. is focused on opportunities in the precision geospatial, forestry analytics, and carbon sector through artificial intelligence (AI). Woodlands.ai is a generative AI natural resources model in development, building digital twins of real-world forests. Digital forests can be manipulated and studied in computer-generated worlds, with the influence of deep machine learning, neural... see more

CSE:AIG - Post Discussion

Genesis AI Corp > Mushrooms - Food, Wellness and Drugs
View:
Post by Banner60 on Apr 12, 2021 1:38pm

Mushrooms - Food, Wellness and Drugs

Mushrooms continue to get lots of press for all of their health, wellness and as a replacement for some highly addidctive pain killer drugs.


https://www.vox.com/platform/amp/the-goods/22372504/mushrooms-food-wellness-drugs
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities